phosphatidylcholines has been researched along with Intraocular Pressure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afify, AEMR; Afify, EAMR; Elsayed, I; Gad, MK; Mohamed, MI | 1 |
| Mahdy, MM; Mokhtar Ibrahim, M; Tawfique, SA | 1 |
| Ang, M; Chattopadhyay, S; Darwitan, A; Natarajan, JV; Venkatraman, SS; Wong, TT | 1 |
3 other study(ies) available for phosphatidylcholines and Intraocular Pressure
| Article | Year |
|---|---|
Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures.
Topics: Animals; Aqueous Humor; Biological Availability; Delayed-Action Preparations; Drug Compounding; Glaucoma; Half-Life; Intraocular Pressure; Male; Nanostructures; Ophthalmic Solutions; Particle Size; Permeability; Phosphatidylcholines; Rabbits; Sulfonamides; Thiophenes | 2018 |
Liposomal diltiazem HCl as ocular drug delivery system for glaucoma.
Topics: Animals; Antihypertensive Agents; Biological Availability; Chemistry, Pharmaceutical; Diltiazem; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Glaucoma; Intraocular Pressure; Microscopy, Electron, Transmission; Phosphatidylcholines; Rabbits; Surface Properties; Unilamellar Liposomes | 2014 |
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.
Topics: Administration, Ophthalmic; Analysis of Variance; Animals; Antihypertensive Agents; Delayed-Action Preparations; Drug Stability; Eye; Female; Glaucoma; Injections, Intraocular; Intraocular Pressure; Latanoprost; Liposomes; Nanomedicine; Particle Size; Phosphatidylcholines; Prostaglandins F, Synthetic; Rabbits | 2012 |